Answers are grounded in this paper and cite their sources.
Background Although severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) primarily affects the respiratory tract, COVID-19 may also be associated with abnormalities in extrapulmonary organs, including the liver. The mechanisms underlying hepatic involvement remain incompletely understood, particularly because angiotensin-converting enzyme 2 (ACE2), a canonical SARS-CoV-2 entry receptor, is reported to be expressed at relatively low levels in hepatocytes. This study investigated hepatic histopathological changes, the tissue distribution of SARS-CoV-2-related signals, and the expression of selected autophagy-associated markers in patients who died from severe COVID-19. Methods Liver samples obtained from patients who died from COVID-19-related respiratory failure were analyzed. Histopathological examination and immunohistochemistry were performed to assess the expression of SARS-CoV-2 proteins and autophagy-related markers, including LC3, p62, Beclin-1 and TOMM20. Fluorescent immunohistochemistry was applied to evaluate the co-localization of SARS-CoV-2 proteins with heparan sulfate. Clinical and laboratory parameters were also evaluated and compared to non-COVID-19 cohort. Results Histopathological analysis revealed variable degrees of liver alterations, including steatosis, endothelial dysfunction, sinusoidal dilatation, and fibrin deposition. Despite lacking ACE2 expression in hepatocytes, SARS-CoV-2 proteins were detected in liver tissue. Fluorescent immunostaining suggested a potential role of heparan sulfate proteoglycans in facilitating viral entry into hepatocytes. Immunohistochemical analysis revealed variable expression patterns of autophagy-associated proteins in the liver specimens, including LC3, p62/SQSTM1, and Beclin-1. Beclin-1 and the mitochondrial outer membrane protein TOMM20 showed increased immunoreactivity in the examined specimens. These findings indicate alterations in the expression of proteins associated with autophagy and mitochondrial status. Conclusions In this autopsy cohort, severe COVID-19 was associated with hepatic histopathological abnormalities and altered expression of selected autophagy-related proteins. The observed overlap between SARS-CoV-2 spike-protein signal and heparan sulfate is compatible with a possible association but does not establish that heparan sulfate mediates viral entry into hepatocytes. For the reason that static immunohistochemistry cannot directly measure autophagic flux or mitophagy, further studies using complementary functional approaches are required to determine the mechanisms underlying these findings.
No takes yet. Share an insight, caveat, or question.
Drácz et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: